Malignant Brain Glioma — Trials

Malignant Brain Glioma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: Nationwide Children's Hospital
Termination share: 40%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04105374	Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma	withdrawn	Phase 2 / Phase 3	0	NRG OncologyOTHER	0	May 7, 2026	clinicaltrials
NCT03632317	A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas	withdrawn	Phase 2	0	University of Michigan Rogel Cancer CenterOTHER	1	Aug 19, 2019